City

Heidelberg (1)

Condition

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Prof. Dr. Richard F Schlenk (1)

Collaborator

Intervention

mrd-triggered arm (1)

prophylactic arm (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

aml according to who 2016 classification (except acute promyelocytic leukemia) and (refractory to induction therapy or relapsed after first line treatment)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)

MRD-triggered arm
Prophylactic Arm

Heidelberg, BW, Germany

University Hospital Heidelberg Med5

Jan 4, 2021